A Durham startup developing a device designed to improve patient outcomes following surgery for prostate cancer has closed a $6.6 million raise
With the funds from the Series A round, Levee Medical aims to scale its infrastructure and expand its team as it continues development on its Voro Urologic Scaffold, a device intended to reduce complications associated with surgical treatment.
In a conversation with Triangle Inno in May, the company shared its plans to move the device through the regulatory…
